Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM. [electronic resource]
Producer: 20171229Description: 370ra180 p. digitalISSN:- 1946-6242
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Neoplasm -- pharmacology
- Antineoplastic Agents -- pharmacology
- Brain Neoplasms -- drug therapy
- Carmustine -- pharmacology
- Cell Line, Tumor
- Disease Models, Animal
- Disease Progression
- Female
- Flow Cytometry
- Glioblastoma -- drug therapy
- Glioma -- drug therapy
- Humans
- Immunosuppressive Agents -- pharmacology
- Immunotherapy
- Mice
- Mice, Inbred C57BL
- Microglia -- metabolism
- Programmed Cell Death 1 Receptor -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.